Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.220
-0.110 (-3.30%)
Oct 2, 2026, 4:08 PM HKT

HKG:1066 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13,59413,38913,08713,22913,74713,209
Revenue Growth
1.53%2.31%-1.08%-3.77%4.08%13.65%
Gross Profit
6,1946,3276,5366,6117,2937,336
Operating Income
1,8001,8462,2742,1813,0433,003
Net Income
1,3781,6122,0672,0022,7642,276
Earnings Per Share
0.300.350.450.440.610.50
EPS Growth
-14.32%-22.22%2.27%-27.92%21.18%9.51%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Eliminations
-83.75-94.07-88.05-45.8-50.8-0.11
Orthopaedic Products
1,4881,5231,4391,2712,0382,127
Blood Management Products
995.24995.11876.781,0421,098976.86
Pharma Packaging Products
2,3752,2882,2792,0242,1052,040
Interventional Products
1,9792,0061,9801,9311,7261,544
Medical Device Products
6,8396,6716,6007,0076,8316,521
Total
13,59213,38913,08713,22913,74713,209

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8,4949,4538,3227,3337,4867,133
Total Debt
4,0745,1034,1934,1694,4914,138
Net Cash (Debt)
4,4204,3494,1293,1642,9952,996
Net Cash Growth
1.64%5.34%30.49%5.65%-0.03%65.65%
Net Cash Per Share
0.980.960.910.700.660.66

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,7472,5512,7902,7992,2953,087
Capital Expenditures
-784.72-784.72-598.05-647.58-1,070-1,120
Free Cash Flow
1,9621,7662,1922,1511,2251,967
Free Cash Flow Growth
11.11%-19.44%1.91%75.63%-37.72%4.56%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.57%47.26%49.94%49.97%53.05%55.54%
Operating Margin
13.24%13.79%17.37%16.49%22.13%22.73%
Pretax Margin
13.52%15.17%19.51%17.91%24.63%21.79%
Profit Margin
10.14%12.04%15.79%15.13%20.11%17.23%
FCF Margin
14.43%13.19%16.75%16.26%8.91%14.89%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1830.1570.2150.1680.1650.142
Dividend Per Share Growth
-29.97%-27.16%28.44%1.64%16.20%9.23%
Dividend Yield
5.68%3.55%5.31%2.70%1.65%2.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.3012.709.5615.7718.7515.75
Forward PE
8.009.058.8211.0217.4812.63
P/FCF Ratio
6.4511.609.0114.6842.3218.23
PS Ratio
0.931.531.512.393.772.71